Status:
COMPLETED
Breast Study to Learn More About the Application of Optical Transillumination Measurements to Assess Breast Cancer Risk and to Potentially Detect the Presence of Breast Cancer.
Lead Sponsor:
University Health Network, Toronto
Conditions:
Breast Cancer
Eligibility:
FEMALE
30-70 years
Brief Summary
This study aims to evaluate if a light based technique, called Transillumination Breast Spectroscopy (TIBS), can be used to construct a non-invasive breast cancer risk predictor which provides a bette...
Detailed Description
In a previous cross sectional study in a group of women without breast cancer and with varying degrees of parenchymal density patterns, a strong association was demonstrated between Transillumination ...
Eligibility Criteria
Inclusion
- Are in good health and capable of providing consent
- Are willing to come in to the Princess Margaret Hospital for a single visit to meet with a female research assistant
Exclusion
- Have had breast augmentation or reduction
- Have a personal history of breast cancer
- Have had a previous bilateral fine needle aspiration or core biopsy
- Have a breast tattoo
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00188721
Start Date
July 1 2006
End Date
September 1 2009
Last Update
August 12 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ontario Cancer Institute, Princess Maraget Hospital
Toronto, Ontario, Canada, M5G 2M9
2
Ontario Cancer Institute, Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9